Jena, Anupam B.; Philipson, Tomas J. - In: Journal of Health Economics 32 (2013) 1, pp. 172-180
Increased health care spending has placed pressure on public and private payers to prioritize spending. Cost-effectiveness (CE) analysis is the main tool used by payers to prioritize coverage of new therapies. We argue that reimbursement based on CE is subject to a form of the “Lucas...